Explore more publications!

Press Releases

DOT & FAA Announce Temporary 10% Reduction in Flights at 40 Airports

DOT & FAA Announce Temporary 10% Reduction in Flights at 40 Airports

AI in Food and Beverage to Reach $50.6 Billion by 2030
KeyCreator 2026 Release Enhances Level Tree Capabilities
Gate Bioscience Announces $65 Million Oversubscribed Series B Financing to Advance Oral Molecular Gate Medicines into the Clinic
Korro Reports Third Quarter Financial Results, Provides Updates on KRRO-110 in Alpha-1 Antitrypsin Deficiency and Additional Pipeline Programs
Biomarker Deals Accelerate: Strategic Alliances Reshape Life Sciences Innovation
JT Thorpe Group, Inc. enters the Canadian refractory market with its acquisition of ThorCan
Inventiva announces launch of public offering
States move to rein in private equity’s growing control of healthcare, new report finds
Flywire Reports Third Quarter 2025 Financial Results
ArchLynk’s Driver App Simplifies Delivery Operations and Boosts Real-Time Visibility Across the Supply Chain
Molecular Partners Presents New Data for DLL3 Targeting Radiotherapy MP0712 at TRP Summit Europe 2025, Highlighting Initial Human Images and Mechanism of Action
Verisk Estimates Insured Losses for Hurricane Melissa Will Range Between USD 2.2 Billion to USD 4.2 Billion
Rocket Software Unveils Next Evolution of DevOps Tools That Evolve the Developer Experience to Bridge IT Skills Gap Across Core IT Systems
Atea Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update
Destination XL Group, Inc. to Announce Third Quarter 2025 Financial Results on Thursday, December 4, 2025
Aloha Life Digital Wins Best Startup at the 2025 US Search Awards
ImageneBio Reports Third Quarter 2025 Financial Results and Provides IMG-007 Program Update Following Closing of Reverse Merger, Concurrent Financing, and Strengthening of Management Team
InStride Health Announces Key Leadership Additions, Promotions to Enhance Payer Engagement, Technical Enablement, and Clinical Operations
Eledon Pharmaceuticals Announces Pricing of $50 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions